Once a day (ie 24 hourly) Kapanol(TM), a new sustained release morphine formulation, in the treatment of cancer pain: Morphine metabolite profiles

被引：0
|
作者：
Cherry, DA [1 ]
Gourlay, GK [1 ]
Onley, MM [1 ]
Tordoff, SG [1 ]
Conn, DA [1 ]
Malden, T [1 ]
机构：
[1] FLINDERS MED CTR,PAIN MANAGEMENT UNIT,BEDFORD PK,SA 5042,AUSTRALIA
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：884 / 884
页数：1
相关论文
共 19 条
  • [1] Once a day (ie 24 hourly) Kapanol(TM), a new sustained release morphine formulation, in the treatment of cancer pain: Pharmacokinetic aspects
    Gourlay, GK
    Cherry, DA
    Onley, MM
    Tordoff, SG
    Conn, DA
    Plummer, JL
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 897 - 897
  • [2] Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine-treatment for cancer pain
    Broomhead, A
    Kerr, R
    Tester, W
    OMeara, P
    Maccarrone, C
    Bowles, R
    Bus, B
    Hodsman, P
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 14 (02) : 63 - 73
  • [3] SINGLE-DOSE PHARMACOKINETICS OF KAPANOL(TM), A NEW ORAL SUSTAINED-RELEASE MORPHINE FORMULATION
    MACCARRONE, C
    WEST, RJ
    BROOMHEAD, AF
    HODSMAN, GP
    DRUG INVESTIGATION, 1994, 7 (05): : 262 - 274
  • [4] Kapanol(TM) capsules - Pellet formulation provides alternative methods of administration of sustained-release morphine sulfate
    Jones, R
    Hale, E
    Talomsin, L
    Phillips, R
    CLINICAL DRUG INVESTIGATION, 1996, 12 (02) : 88 - 93
  • [5] The pharmacokinetic profiles of two variations of a sustained release morphine sulfate formulation intended for once-daily administration
    Guelen, PJM
    Janssen, TJ
    Donazollo, YR
    Debregeas, SP
    CLINICAL DRUG INVESTIGATION, 1997, 14 (Suppl 1) : 53 - 58
  • [6] The Pharmacokinetic Profiles of Two Variations of a Sustained Release Morphine Sulfate Formulation Intended for Once-Daily Administration
    Pieter J. M. Guelen
    Tom J. Janssen
    Yves R. Donazollo
    Sabine P. Debregeas
    Clinical Drug Investigation, 1997, 14 : 53 - 58
  • [7] Pain, sedation and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine
    Andersen, G
    Jensen, NH
    Christrup, L
    Hansen, SH
    Sjogren, P
    PALLIATIVE MEDICINE, 2002, 16 (02) : 107 - 114
  • [8] SUSTAINED-RELEASE MORPHINE TABLETS IN THE LONG-TERM TREATMENT OF CANCER PAIN
    SORGE, J
    LEHMKUHL, C
    LOHSE, K
    HERRMANN, H
    PICHLMAYR, I
    MEDIZINISCHE KLINIK, 1990, 85 (09) : 523 - 528
  • [9] Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer
    Ozturk, Tulun
    Karadibak, Kaan
    Catal, Deniz
    Cakan, Aydan
    Tugsavul, Fevziye
    Cirak, Kadri
    AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY, 2008, 20 (03): : 20 - 25
  • [10] Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond
    Ruan, Xiulu
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (07) : 999 - 1001
12